QATCH Technologies is a life-science instrumentation start-up, and was founded to commercialize a sensor technology developed at Duke University. QATCH is currently developing a tool to prescreen injectability and manufacturability of biopharmaceutical drugs at an early stage of drug development due to the very low volume needed (μLs). QATCH's proprietary technology can de-risk preclinical phase for biopharmaceutical drug development and prevent delays for crucial medicines reaching patients.